Welcome to the Institute of Clinical Research

Welcome to the Institute of Clinical Research

About Us

The Institute of Clinical Research (ICR) is the probably the oldest independent membership-led professional body for global clinical researchers.  

For over 40 years, The Institute of Clinical Research (ICR) has provided high quality training, networking and support to the clinical research community.  For many Members the Institute has been part of their life throughout their working careers, many have been with the Institute since its first incarnation as the ACRPI.

It is the membership that makes the Institute.

How does it all work ?

The Institute of Clinical Research is you, the Membership governed by the Articles of Memorandum drawn up by the founding members.

The Board is made up of members who give their time freely to guide the future direction of the ICR.

The ICR Secretariat is the administrative arm of the Institute, its primary focus is to ensure that the wishes of the Board and Membership are carried out and to see to the day to day tasks that any membership organisation generates.

  

Our Mission

The ICR exists to support our members through all stages of their careers. We do this, in part, by:

  • Defining and refining standards for our profession
  • Providing a forum for discussion of key issues impacting clinical research
  • Promoting good relations with other healthcare related groups 
  • Providing opportunities for learning and development to enhance professional competence 
  • Enhancing public confidence and understanding of clinical research

 

Current News

Future of Intercept’s NASH drug in doubt after FDA panel rejection

By ICR Secretariat / 30/05/2023 03:56 PM

Advisers to the Food and Drug Administration on Friday recommended against approving an experimental drug for a common fatty liver disease called NASH…

'The Top Line': 2023's biopharma layoffs, plus this week's headlines

By ICR Secretariat / 30/05/2023 03:55 PM

Layoffs have hit biopharma hard over the last year and a half. In this episode Fierce Biotech's Max Bayer and Gabrielle Mason will discuss the recent …

How the digital front door benefits clinical trial patients, clinicians and sponsors

By ICR Secretariat / 30/05/2023 03:53 PM

Opening the digital front door to clinical trials means creating a great user experience for patients, clinicians and ultimately sites and sponsors. A…


Immuneering reveals positive data from tumour treatment trial

By ICR Secretariat / 03/05/2023 11:12 AM

Immuneering – a company developing medicines for cancer patients – has announced positive pharmacodynamic (PD) and pharmacokinetic (PK) safety data fr…

In heavyweight obesity fight, Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy

By ICR Secretariat / 03/05/2023 11:11 AM

The stakes are getting even higher in the fight for supremacy between Eli Lilly and Novo Nordisk in the multibillion-dollar obesity market. Eli Lilly …

Shared vision for Boehringer Ingelheim and RetinAI

By ICR Secretariat / 03/05/2023 11:09 AM

Companies will collaborate to boost novel treatments for individuals with geographic atrophy

RetinAI Medical – a company focused on clinical and imag…


Avacta doses first patient in pivotal phase 1a trial

By ICR Secretariat / 17/04/2023 09:49 AM

Avacta – a company developing targeted oncology drugs and diagnostics – has announced that the first individual has been dosed with its AVA6000 candid…

Biotech fears ‘dangerous’ precedent as judge challenges FDA authority

By ICR Secretariat / 17/04/2023 09:48 AM

A federal judge’s decision to revoke the approval of an abortion pill rippled across the biotechnology industry over the weekend, as industry leaders …

Johnson & Johnson's $8.9B bankruptcy settlement is 'unworkable,' talc plaintiff lawyer says

By ICR Secretariat / 17/04/2023 09:46 AM

Are plaintiffs who are suing Johnson & Johnson for its talc products ready to approve an $8.9 billion settlement to resolve their claims through a…


Sanofi, Regeneron surge as Dupixent scores in COPD trial

By ICR Secretariat / 05/04/2023 02:28 PM

  • An anti-inflammatory drug from Sanofi and Regeneron succeeded in a Phase 3 clinical trial in chronic obstructive pulmonary disease, giving the medic…

GSK plays defense after California judge approves plaintiff's expert testimony in high-stakes Zantac trial

By ICR Secretariat / 05/04/2023 02:27 PM

After eluding thousands of federal lawsuits because a U.S. district judge rejected the science behind plaintiffs’ claims, GSK will be forced to defend…

ICR Spring Ethics & GCP Forum

By ICR Secretariat / 07/02/2023 10:26 AM

 

We would like to say a huge Thank You to the Ethics & GCP Committee & Speakers, and all who attended and supported a successful return to o…


Trial blazing

By ICR Secretariat / 07/02/2023 09:47 AM

A look at the latest progress in digitised clinical trials suggests that decentralisation does deliver

There has been significant progress in decentr…

AstraZeneca targets the 9 out of 10 people who don't know they have CKD in new TV spot

By ICR Secretariat / 07/02/2023 09:45 AM

AstraZeneca’s latest DTC spot “We Are Targets” for its chronic kidney disease (CKD) med Farxiga is aimed squarely at the nine in 10 adults who have CK…

Gilead’s CAR T-cell therapy recommended for use across the NHS

By ICR Secretariat / 07/02/2023 09:43 AM

Treatment involves adult patients with relapsed or refractory diffuse large B-cell lymphoma

Gilead Sciences has announced that the National Institute…


Sanofi launches new scholarship program to boost diversity in healthcare

By ICR Secretariat / 30/01/2023 10:14 AM

Citing the “trust gap” as one of the greatest challenges in global health today, Sanofi announced its new NextGen Scholarship program, a global initia…

10 clinical trials to watch in the first half of 2023

By ICR Secretariat / 19/01/2023 03:56 PM

The biotechnology industry begins 2023 at a crossroads.

In many ways, the sector is coming off of one of its toughest years in recent memory. Initial…

Course Postponements Due to Covid

By ICR Secretariat / 10/02/2022 03:38 PM

All of our delegates and members who had course places postponed over the last two years due to covid restrictions/illness have now been contacted dir…




Events and Courses

Clinical Investigations for Medical Devices - Foundation M17

In this one day course we explore clinical investigations for medical devices.  We will review the latest legislation and its impact on dete...


Statistics for Non-Statisticians M13

Statistics is the art and science of summarising data.  Statistics play an essential role in all stages of clinical research ...


Advanced Monitoring M20

In this highly practical course we look at the root cause of typical inspection findings and work with delegates to develop personal corrective a...


Effective Project Management for Clinical Trials (3 Days ) M19

This practical course provides delegates with basic project management techniques that can be applied to clinical trial project management. Learning i...


Foundation in Good Clinical Practice (GCP) M22

This course provides an in-depth look at the regulatory systems currently in operation in the EU and their impact, together with UK legislation, on...


Clinical Trial Administration - Beyond the Basics M23

Clinical Trial Administrators are at the heart of any project team...


Current Jobs